Calcium Channel Blockers Compared to Magnesium Sulfate in Fetal Cerebral Blood Flow
Status:
Completed
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate the possible use of calcium channel as a
neuroprotectant in cases with PTL. This will be done by comparing the effect they have on
cerebral blood vessels with the already established MgSo4. They have been proven superior to
magnesium sulphate in tocolysis, and they possess the mechanism of action that would allow
for their theoretical use as neuroprotective agents.